Australia’s CSL taps Amazon’s cloud unit to boost research pipeline
AWS logo is seen in this illustration taken October 20, 2025. REUTERS/Dado Ruvic/Illustration
Read a summary of this article on FAST.
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
Sept 29 : Australian biotechnology firm CSL said on Tuesday it is collaborating with Amazon’s cloud arm to harness AI and cloud technology across its research and clinical development pipeline.
Here are some more details:
• The partnership with Amazon Web Services (AWS) will enable CSL’s scientists to analyse complex scientific data and identify potential drug targets earlier in the discovery process, helping to accelerate research and shorten development timelines, the company said.
• On the clinical front, CSL said it will also use AWS’s cloud and AI tools to reduce manual workloads in protocol drafting, data management, and submission processes.
Guess Word
Crack the word, one row at a time
Buzzword
Create words using the given letters
Mini Sudoku
Tiny puzzle, mighty brain teaser
Mini Crossword
Small grid, big challenge
Word Search
Spot as many words as you can
• The firm aims to link laboratory and computational work more closely, enabling experimental findings to inform research models and decisions faster.
• The partnership with Seattle-based AWS comes after US President Donald Trump announced a new round of drug-pricing agreements with international pharmaceutical companies, including CSL, in early September.
• In mid-August, CSL posted better-than-expected annual underlying earnings and forecast growth in 2027 on the back of its core plasma division.
• Shares of CSL were largely unchanged at A$181.9, as of 0023 GMT.
Source: Reuters
Sign up for our newsletters
Get the CNA app
Stay updated with notifications for breaking news and our best stories
Get WhatsApp alerts
Join our channel for the top reads for the day on your preferred chat app
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
